You all for being here. I look forward to our conversation. Mister lynch, im like to direct the first question to you. It seems to me that its safe to say that the general view of government in the United States is that its broken and dysfunctional. Im reminded of a book that was published in 2012 called its worse than it looks. Is our government really in as bad a shape as popular opinion would have it . James probably, in the big picture i would say there are a lot of things that we can find that arent working in government. I would say probably more so at the federal level than at the local level, but im sure jeff could tell us that there are things that arent working at the state level too. Theres a lot. We can find lots of reasons why things arent working. Theres a lack of interest sometimes. Theres special interest in other cases, but yeah, i think by and large people arent confident the government is working and working well. Craig doctor hoffman, from what i remember of my soci
Prescription drug corporation. Jon, thank you for coming over from des moines. Jon rosmann thahas for the opportunity. Craig vansandt as i said, our topic t tay is the ethics of drug pricing. There has been no shortage of news this fall about price increases with prescription drugs. If you read the news, you see that prices, or at least it seems to be, that prices are going up very rapdly. Ben, id like to start off f e questions with you as a phd student. Is the popular press giving us an accurate picture . Are prices going up this rapidly . Ben urick you know, i would say it depends on the medications you look at. If we talk about brand name pharmaceuticals, the answer is yes. Certainly things like sovaldi, made by gilead pharmaceutut als, for hepatitis c, coming out at 86,000 is an incredible price to pay for a know, im sure many of the viewers have heard about daraprim that was purchased by Turing Pharmaceuticals who then increased the price 5000 . Now, those are extreme cases but i
Transcripts For KCRG Ethical Perspectives On The News 20160117 archive.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from archive.org Daily Mail and Mail on Sunday newspapers.
Dr. Ghosh thank you. Craig vansandt were also very happy to have jon rosmann with us, who is the executive director of the iowow Prescription Drug corporation. Jon, thank you for coming over from des moines. Jon rosmann thanks for the opportunity. Craig vansandt as i said, our topic today is the ethics of drug pricing. There hasseen no shortage of news this fall about price increases with Prescription Drugs. If you read the news, you see that prices, or at least it seems to be, that prices are going up very rapidly. Ben, id like to start off the questions with you as a phd studenen is the popular press giving us an accurate picture . Are ben urick you knono i would say it depends on the medications you look at. If we talk about brand name pharmaceuticals, the answer is yes. Certainly gilead pharmaceutic als, for hepatitis c, comimi out at 86,000 is an incredible price to pay for a therapy like that. You know, im sure many of the viewers have heard about daraprim that was purchased by T